The 2-Minute Rule for Is ABBV-744 effective for hematologic cancers?
In Segment C, members will obtain ABBV-744 and oral navitoclax. In Section D, participants will obtain ABBV-744 and ruxolitinib. Contributors will receive treatment till disease progression or perhaps the contributors are unable to tolerate the study drugs.Ubiquitin-similar proteins that regulate the stability of critical Tremendous enhancer-mediat